Inovio reports early flu vaccine results; Supercomputer Watson donates winnings to malaria research;

> Inovio Pharmaceuticals ($INO) said a Phase I trial of its avian flu vaccine SynCon generated HAI titers against six different strains of H5N1, presenting a possible development path for a universal flu vaccine. Inovio release

> Bionor Pharma's universal influenza vaccine, Vacc-Flu, reduced serious flu symptoms by 25% in an animal study. Bionor release

> The U.S. is reaching out to Australia's Commonwealth Scientific and Industrial Research Organization to help with development of vaccines to combat bioterrorism. Article

> 10 promising therapeutic vaccines to watch. Article

And Finally... IBM, which developed JEOPARDY! champion Watson, is donating half of the supercomputer's $1 million in winnings to Scripp Research Institute to conduct malaria research. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.